Market Analysis and Insights:
The global Organ On Chip market size is projected to reach US$ 487 million by 2028, from US$ 60 million in 2021, at a CAGR of 33.03% during 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Organ On Chip market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Organ On Chip market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Organ On Chip market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Organ On Chip market.
Scope and Market Size:
Organ On Chip market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Organ On Chip market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2017-2028.
By Company
- Emulate
- Mimetas
- TissUse
- Tara Biosystems
- CN Bio Innovations
- Hesperos
- Draper Laboratory
- Nortis
- Micronit Microtechnologies B.V.
- Kirkstall
- Cherry Biotech SAS
- Else Kooi Laboratory
- Altis Biosystems
- Bi/ond
- Netri
- Beijing Daxiang Biotech
Segment by Type
- Brain-on-a-chip
- Liver-on-a-chip
- Kidney-on-a-chip
- Lung-on-a-chip
- Heart-on-a-chip
- Intestine-on-a-chip
- Vessel-on-a-chip
- Other Organs
Segment by Application
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Cosmetics Industry
- Others
By Region
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- Europe
- Germany
- France
- U.K.
- Netherlands
- Nordic Countries
- Rest of Europe
- South America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
TABLE OF CONTENTS
1 REPORT OVERVIEW
- 1.1 STUDY SCOPE
- 1.2 MARKET ANALYSIS BY TYPE
- 1.2.1 GLOBAL ORGAN ON CHIP MARKET SIZE GROWTH RATE BY TYPE: 2017 VS 2021 VS 2028
- 1.2.2 BRAIN-ON-A-CHIP
- 1.2.3 LIVER-ON-A-CHIP
- 1.2.4 KIDNEY-ON-A-CHIP
- 1.2.5 LUNG-ON-A-CHIP
- 1.2.6 HEART-ON-A-CHIP
- 1.2.7 INTESTINE-ON-A-CHIP
- 1.2.8 VESSEL-ON-A-CHIP
- 1.3 MARKET BY APPLICATION
- 1.3.1 GLOBAL ORGAN ON CHIP MARKET SHARE BY APPLICATION: 2017 VS 2021 VS 2028
- 1.3.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 1.3.3 ACADEMIC & RESEARCH INSTITUTES
- 1.3.4 COSMETICS INDUSTRY
- 1.4 STUDY OBJECTIVES
- 1.5 YEARS CONSIDERED
2 GLOBAL GROWTH TRENDS
- 2.1 GLOBAL ORGAN ON CHIP MARKET PERSPECTIVE (2017-2028)
- 2.2 ORGAN ON CHIP GROWTH TRENDS BY REGION
- 2.2.1 ORGAN ON CHIP MARKET SIZE BY REGION: 2017 VS 2021 VS 2028
- 2.2.2 ORGAN ON CHIP HISTORIC MARKET SIZE BY REGION (2017-2022)
- 2.2.3 ORGAN ON CHIP FORECASTED MARKET SIZE BY REGION (2023-2028)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
- 3.1 GLOBAL TOP ORGAN ON CHIP PLAYERS BY REVENUE
- 3.1.1 GLOBAL TOP ORGAN ON CHIP PLAYERS BY REVENUE (2017-2022)
- 3.1.2 GLOBAL ORGAN ON CHIP REVENUE MARKET SHARE BY PLAYERS (2017-2022)
- 3.2 GLOBAL ORGAN ON CHIP MARKET SHARE BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3)
- 3.3 PLAYERS COVERED: RANKING BY ORGAN ON CHIP REVENUE
- 3.4 GLOBAL ORGAN ON CHIP MARKET CONCENTRATION RATIO
- 3.4.1 GLOBAL ORGAN ON CHIP MARKET CONCENTRATION RATIO (CR5 AND HHI)
- 3.4.2 GLOBAL TOP 3 AND TOP 5 COMPANIES BY ORGAN ON CHIP REVENUE IN 2021
- 3.5 ORGAN ON CHIP KEY PLAYERS HEAD OFFICE AND AREA SERVED
- 3.6 KEY PLAYERS ORGAN ON CHIP PRODUCT SOLUTION AND SERVICE
- 3.7 FUNDING/INVESTMENT ANALYSIS
4 ORGAN ON CHIP BREAKDOWN DATA BY TYPE
- 4.1 GLOBAL ORGAN ON CHIP HISTORIC MARKET SIZE BY TYPE (2017-2022)
- 4.2 GLOBAL ORGAN ON CHIP FORECASTED MARKET SIZE BY TYPE (2023-2028)
5 ORGAN ON CHIP BREAKDOWN DATA BY APPLICATION
- 5.1 GLOBAL ORGAN ON CHIP HISTORIC MARKET SIZE BY APPLICATION (2017-2022)
- 5.2 GLOBAL ORGAN ON CHIP FORECASTED MARKET SIZE BY APPLICATION (2023-2028)
6 NORTH AMERICA
- 6.1 NORTH AMERICA ORGAN ON CHIP MARKET SIZE (2017-2028)
- 6.2 NORTH AMERICA ORGAN ON CHIP MARKET SIZE BY COUNTRY (2017-2022)
- 6.3 NORTH AMERICA ORGAN ON CHIP MARKET SHARE BY COUNTRY (2023-2028)
- 6.4 UNITED STATES
- 6.5 CANADA
7 EUROPE
- 7.1 EUROPE ORGAN ON CHIP MARKET SIZE (2017-2028)
- 7.2 EUROPE ORGAN ON CHIP MARKET SIZE BY COUNTRY (2017-2022)
- 7.3 EUROPE ORGAN ON CHIP MARKET SIZE BY COUNTRY (2023-2028)
- 7.4 GERMANY
- 7.5 FRANCE
- 7.6 U.K.
- 7.7 NETHERLANDS
- 7.8 NORDIC COUNTRIES
8 ASIA-PACIFIC
- 8.1 ASIA-PACIFIC ORGAN ON CHIP MARKET SIZE (2017-2028)
- 8.2 ASIA-PACIFIC ORGAN ON CHIP MARKET SIZE BY REGION (2017-2022)
- 8.3 ASIA-PACIFIC ORGAN ON CHIP MARKET SIZE BY REGION (2023-2028)
- 8.4 CHINA
- 8.5 JAPAN
- 8.6 SOUTH KOREA
- 8.7 SOUTHEAST ASIA
- 8.8 INDIA
9 LATIN AMERICA
- 9.1 LATIN AMERICA ORGAN ON CHIP MARKET SIZE (2017-2028)
- 9.2 LATIN AMERICA ORGAN ON CHIP MARKET SIZE BY COUNTRY (2017-2022)
- 9.3 LATIN AMERICA ORGAN ON CHIP MARKET SIZE BY COUNTRY (2023-2028)
- 9.4 MEXICO
- 9.5 BRAZIL
10 MIDDLE EAST & AFRICA
- 10.1 MIDDLE EAST & AFRICA ORGAN ON CHIP MARKET SIZE (2017-2028)
- 10.2 MIDDLE EAST & AFRICA ORGAN ON CHIP MARKET SIZE BY COUNTRY (2017-2022)
- 10.3 MIDDLE EAST & AFRICA ORGAN ON CHIP MARKET SIZE BY COUNTRY (2023-2028)
- 10.4 TURKEY
- 10.5 SAUDI ARABIA
- 10.6 UAE
11 KEY PLAYERS PROFILES
- 11.1 EMULATE
- 11.1.1 EMULATE COMPANY DETAILS
- 11.1.2 EMULATE BUSINESS OVERVIEW
- 11.1.3 EMULATE ORGAN ON CHIP INTRODUCTION
- 11.1.4 EMULATE REVENUE IN ORGAN ON CHIP BUSINESS (2017-2022)
- 11.2 MIMETAS
- 11.2.1 MIMETAS COMPANY DETAILS
- 11.2.2 MIMETAS BUSINESS OVERVIEW
- 11.2.3 MIMETAS ORGAN ON CHIP INTRODUCTION
- 11.2.4 MIMETAS REVENUE IN ORGAN ON CHIP BUSINESS (2017-2022)
- 11.3 TISSUSE
- 11.3.1 TISSUSE COMPANY DETAILS
- 11.3.2 TISSUSE BUSINESS OVERVIEW
- 11.3.3 TISSUSE ORGAN ON CHIP INTRODUCTION
- 11.3.4 TISSUSE REVENUE IN ORGAN ON CHIP BUSINESS (2017-2022)
- 11.4 TARA BIOSYSTEMS
- 11.4.1 TARA BIOSYSTEMS COMPANY DETAILS
- 11.4.2 TARA BIOSYSTEMS BUSINESS OVERVIEW
- 11.4.3 TARA BIOSYSTEMS ORGAN ON CHIP INTRODUCTION
- 11.4.4 TARA BIOSYSTEMS REVENUE IN ORGAN ON CHIP BUSINESS (2017-2022)
- 11.5 CN BIO INNOVATIONS
- 11.5.1 CN BIO INNOVATIONS COMPANY DETAILS
- 11.5.2 CN BIO INNOVATIONS BUSINESS OVERVIEW
- 11.5.3 CN BIO INNOVATIONS ORGAN ON CHIP INTRODUCTION
- 11.5.4 CN BIO INNOVATIONS REVENUE IN ORGAN ON CHIP BUSINESS (2017-2022)
- 11.6 HESPEROS
- 11.6.1 HESPEROS COMPANY DETAILS
- 11.6.2 HESPEROS BUSINESS OVERVIEW
- 11.6.3 HESPEROS ORGAN ON CHIP INTRODUCTION
- 11.6.4 HESPEROS REVENUE IN ORGAN ON CHIP BUSINESS (2017-2022)
- 11.7 DRAPER LABORATORY
- 11.7.1 DRAPER LABORATORY COMPANY DETAILS
- 11.7.2 DRAPER LABORATORY BUSINESS OVERVIEW
- 11.7.3 DRAPER LABORATORY ORGAN ON CHIP INTRODUCTION
- 11.7.4 DRAPER LABORATORY REVENUE IN ORGAN ON CHIP BUSINESS (2017-2022)
- 11.8 NORTIS
- 11.8.1 NORTIS COMPANY DETAILS
- 11.8.2 NORTIS BUSINESS OVERVIEW
- 11.8.3 NORTIS ORGAN ON CHIP INTRODUCTION
- 11.8.4 NORTIS REVENUE IN ORGAN ON CHIP BUSINESS (2017-2022)
- 11.9 MICRONIT MICROTECHNOLOGIES B.V.
- 11.9.1 MICRONIT MICROTECHNOLOGIES B.V. COMPANY DETAILS
- 11.9.2 MICRONIT MICROTECHNOLOGIES B.V. BUSINESS OVERVIEW
- 11.9.3 MICRONIT MICROTECHNOLOGIES B.V. ORGAN ON CHIP INTRODUCTION
- 11.9.4 MICRONIT MICROTECHNOLOGIES B.V. REVENUE IN ORGAN ON CHIP BUSINESS (2017-2022)
- 11.10 KIRKSTALL
- 11.10.1 KIRKSTALL COMPANY DETAILS
- 11.10.2 KIRKSTALL BUSINESS OVERVIEW
- 11.10.3 KIRKSTALL ORGAN ON CHIP INTRODUCTION
- 11.10.4 KIRKSTALL REVENUE IN ORGAN ON CHIP BUSINESS (2017-2022)
- 11.11 CHERRY BIOTECH SAS
- 11.11.1 CHERRY BIOTECH SAS COMPANY DETAILS
- 11.11.2 CHERRY BIOTECH SAS BUSINESS OVERVIEW
- 11.11.3 CHERRY BIOTECH SAS ORGAN ON CHIP INTRODUCTION
- 11.11.4 CHERRY BIOTECH SAS REVENUE IN ORGAN ON CHIP BUSINESS (2017-2022)
- 11.12 ELSE KOOI LABORATORY
- 11.12.1 ELSE KOOI LABORATORY COMPANY DETAILS
- 11.12.2 ELSE KOOI LABORATORY BUSINESS OVERVIEW
- 11.12.3 ELSE KOOI LABORATORY ORGAN ON CHIP INTRODUCTION
- 11.12.4 ELSE KOOI LABORATORY REVENUE IN ORGAN ON CHIP BUSINESS (2017-2022)
- 11.13 ALTIS BIOSYSTEMS
- 11.13.1 ALTIS BIOSYSTEMS COMPANY DETAILS
- 11.13.2 ALTIS BIOSYSTEMS BUSINESS OVERVIEW
- 11.13.3 ALTIS BIOSYSTEMS ORGAN ON CHIP INTRODUCTION
- 11.13.4 ALTIS BIOSYSTEMS REVENUE IN ORGAN ON CHIP BUSINESS (2017-2022)
- 11.14 BI/OND
- 11.14.1 BI/OND COMPANY DETAILS
- 11.14.2 BI/OND BUSINESS OVERVIEW
- 11.14.3 BI/OND ORGAN ON CHIP INTRODUCTION
- 11.14.4 BI/OND REVENUE IN ORGAN ON CHIP BUSINESS (2017-2022)
- 11.15 NETRI
- 11.15.1 NETRI COMPANY DETAILS
- 11.15.2 NETRI BUSINESS OVERVIEW
- 11.15.3 NETRI ORGAN ON CHIP INTRODUCTION
- 11.15.4 NETRI REVENUE IN ORGAN ON CHIP BUSINESS (2017-2022)
- 11.16 BEIJING DAXIANG BIOTECH
- 11.16.1 BEIJING DAXIANG BIOTECH COMPANY DETAILS
- 11.16.2 BEIJING DAXIANG BIOTECH BUSINESS OVERVIEW
- 11.16.3 BEIJING DAXIANG BIOTECH ORGAN ON CHIP INTRODUCTION
- 11.16.4 BEIJING DAXIANG BIOTECH REVENUE IN ORGAN ON CHIP BUSINESS (2017-2022)
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
- 12.1 ORGAN ON CHIP INDUSTRY CHAIN ANALYSIS
- 12.2 ORGAN ON CHIP KEY RAW MATERIALS
- 12.2.1 KEY RAW MATERIALS
- 12.2.2 RAW MATERIALS KEY SUPPLIERS
- 12.3 ORGAN ON CHIP PRODUCTION MODE & PROCESS
- 12.4 ORGAN ON CHIP SALES AND MARKETING
- 12.4.1 ORGAN ON CHIP SALES CHANNELS
- 12.4.2 ORGAN ON CHIP DISTRIBUTORS
- 12.5 ORGAN ON CHIP CUSTOMERS
13 ORGAN ON CHIP MARKET DYNAMICS
- 13.1.1 ORGAN ON CHIP INDUSTRY TRENDS
- 13.1.2 ORGAN ON CHIP MARKET DRIVERS
- 13.1.3 ORGAN ON CHIP MARKET CHALLENGES
- 13.1.4 ORGAN ON CHIP MARKET RESTRAINTS
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
- 15.1 RESEARCH METHODOLOGY
- 15.1.1 METHODOLOGY/RESEARCH APPROACH
- 15.1.2 DATA SOURCE
- 15.2 DISCLAIMER
- 15.3 AUTHOR DETAILS